CytomX Therapeutics, Inc. (CTMX): Total Assets
$151.57M
As of 2025-12-31
$381.23M
As of 2026-06-30
-16.6%
3-year compound annual growth
-15.8%
5-year compound annual growth
-2.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $151.57M | +25.7% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $120.53M | -40.3% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $201.79M | -22.7% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $260.89M | -23.1% | 2024-03-11, Balance as of period end |
| 2021-12-31 | $339.41M | -5.4% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $358.66M | +5.1% | 2023-03-27, Balance as of period end |
| 2019-12-31 | $341.28M | -25.3% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $457.11M | +15.0% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $397.64M | +99.7% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $199.13M | +1.0% | 2018-03-07, Balance as of period end |
| 2015-12-31 | $197.22M | +169.9% | 2017-03-02, Balance as of period end |
| 2014-12-31 | $73.06M | n/a | 2016-03-07, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $151.57M | +25.7% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $1.36B | -0.3% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $92.11M | +21.0% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $717.60M | -25.0% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $257.59M | +116.2% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $323.15M | +0.4% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $899.42M | +21.1% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $271.15M | -21.2% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $57.15M | -3.5% |
Compare CTMX, ABCL, ETON, BCYC side by side · Screen every company in Pharmaceutical Preparations ↗